- Home
- PMCB vs GCTK Comparison
PMCB vs GCTK Comparison
Compare PMCB & GCTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMCB
- GCTK
- Stock Information
- Founded
- PMCB 1996
- GCTK 2001
- Country
- PMCB United States
- GCTK United States
- Employees
- PMCB N/A
- GCTK N/A
- Industry
- PMCB Biotechnology: Biological Products (No Diagnostic Substances)
- GCTK Medical/Dental Instruments
- Sector
- PMCB Health Care
- GCTK Health Care
- Exchange
- PMCB Nasdaq
- GCTK Nasdaq
- Market Cap
- PMCB 6.6M
- GCTK 5.9M
- IPO Year
- PMCB N/A
- GCTK N/A
- Fundamental
- Price
- PMCB $0.80
- GCTK $5.21
- Analyst Decision
- PMCB
- GCTK
- Analyst Count
- PMCB 0
- GCTK 0
- Target Price
- PMCB N/A
- GCTK N/A
- AVG Volume (30 Days)
- PMCB 42.7K
- GCTK 44.0K
- Earning Date
- PMCB 12-12-2025
- GCTK 11-13-2025
- Dividend Yield
- PMCB N/A
- GCTK N/A
- EPS Growth
- PMCB N/A
- GCTK N/A
- EPS
- PMCB 0.01
- GCTK N/A
- Revenue
- PMCB N/A
- GCTK N/A
- Revenue This Year
- PMCB N/A
- GCTK N/A
- Revenue Next Year
- PMCB N/A
- GCTK N/A
- P/E Ratio
- PMCB $125.04
- GCTK N/A
- Revenue Growth
- PMCB N/A
- GCTK N/A
- 52 Week Low
- PMCB $0.75
- GCTK $4.22
- 52 Week High
- PMCB $1.93
- GCTK $468.00
- Technical
- Relative Strength Index (RSI)
- PMCB 29.41
- GCTK 35.66
- Support Level
- PMCB $0.79
- GCTK $5.39
- Resistance Level
- PMCB $0.93
- GCTK $6.04
- Average True Range (ATR)
- PMCB 0.06
- GCTK 0.33
- MACD
- PMCB -0.01
- GCTK -0.11
- Stochastic Oscillator
- PMCB 16.01
- GCTK 2.92
About PMCB PharmaCyte Biotech Inc.
PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.
About GCTK GlucoTrack Inc.
GlucoTrack Inc is a medical device company. It is focused on defining novel approaches that make diabetes management more accurate and convenient for daily living. The company has developed the GlucoTrack model that measures real-time blood glucose levels. The Company is developing an long-term implantable continuous blood glucose monitoring (CBGM) system, built on healthcare technologies. It is designed to meet the critical needs of insulin-dependent individuals or those at risk of hypoglycemia in the U.S.